CPMV — Mosaic Immunoengineering Balance Sheet
0.000.00%
Last trade - 00:00
- $3.98m
- $5.03m
2018 May 31st | C2019 May 31st | 2020 May 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2.3 | 1.54 | 0.572 | 0.226 | 0.221 |
Net Total Receivables | — | 0.026 | 0.026 | 0 | — |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2.33 | 1.79 | 0.785 | 0.269 | 0.261 |
Net Property, Plant And Equipment | 0.001 | 0.001 | 0 | — | — |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 2.58 | 1.92 | 0.819 | 0.269 | 0.261 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.085 | 0.228 | 0.183 | 2.33 | 3.92 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.085 | 0.228 | 0.183 | 3.07 | 5.15 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | 2.5 | 1.7 | 0.636 | -2.8 | -4.88 |
Total Liabilities & Shareholders' Equity | 2.58 | 1.92 | 0.819 | 0.269 | 0.261 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |